Literature DB >> 30541001

Association of Circulating Adipsin, Visfatin, and Adiponectin with Nonalcoholic Fatty Liver Disease in Adults: A Case-Control Study.

Yun Qiu1,2, Su-Fan Wang1,2, Chao Yu3, Qian Chen1,2, Rui Jiang1,2, Lei Pei1,2, Yuan-Ling Huang1,2, Neng-Zhi Pang1,2, Zhenfeng Zhang4, Wenhua Ling1,2, Lili Yang5,6.   

Abstract

BACKGROUND/AIMS: Some adipokines, such as adiponectin and leptin, have been reported to be involved in the pathogenesis of nonalcoholic fatty liver disease (NAFLD), while the association of adipsin and visfatin with NAFLD still remains unclear. This study aimed to examine the association of circulating adipsin, visfatin, and adiponectin with NAFLD in Chinese adults.
METHODS: We recruited a total of 211 eligible subjects, including 100 NAFLD cases and 111 age and sex frequency-matched controls. Circulating adipsin, visfatin, and adiponection concentrations were measured by enzymatic immunoassay. Unconditional logistic regression was conducted to assess the associations between quartiles of adipokines and NAFLD.
RESULTS: Compared with the controls, NAFLD cases had higher levels of adipsin and lower levels of visfatin and adiponectin. By multivariate logistic analysis, adjusting for potential confounders, circulating adipsin levels were found to be positively associated with NAFLD risk, and circulating levels of visfatin and adiponectin were inversely associated with the risk of NAFLD (all p-trend < 0.05). The ORs were 3.76 (95% CI 1.27-11.08) for adipsin, 0.30 (95% CI 0.10-0.91) for visfatin, and 0.30 (95% CI 0.10-0.88) for adiponectin comparing subjects in the highest quartile with those in the lowest. After stratified by obesity status, the association of higher adipsin with increased risk of NAFLD was only observed in nonobese group. Additionally, the inverse association between adiponectin and NAFLD was found in both groups.
CONCLUSIONS: These results indicated that increased circulating levels of adipsin and decreased circulating levels of visfatin and adiponectin were independently associated with the increased risk of NAFLD.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Adipokines; Adiponectin; Adipsin; Nonalcoholic fatty liver disease; Visfatin

Mesh:

Substances:

Year:  2018        PMID: 30541001     DOI: 10.1159/000495215

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  8 in total

Review 1.  Chronic Inflammation-A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue.

Authors:  Maria Petrescu; Sonia Irina Vlaicu; Lorena Ciumărnean; Mircea Vasile Milaciu; Codruța Mărginean; Mira Florea; Ștefan Cristian Vesa; Monica Popa
Journal:  Medicina (Kaunas)       Date:  2022-05-06       Impact factor: 2.948

2.  Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects.

Authors:  Mayu Kyohara; Jun Shirakawa; Tomoko Okuyama; Yu Togashi; Ryota Inoue; Jinghe Li; Daisuke Miyashita; Yasuo Terauchi
Journal:  Diabetol Metab Syndr       Date:  2020-09-29       Impact factor: 3.320

3.  Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy Controls.

Authors:  Bertha Araceli Marin-Alejandre; Itziar Abete; Irene Cantero; Jose I Riezu-Boj; Fermín I Milagro; J Ignacio Monreal; Mariana Elorz; José Ignacio Herrero; Alberto Benito-Boillos; Jorge Quiroga; Ana Martinez-Echeverria; Juan Isidro Uriz-Otano; María Pilar Huarte-Muniesa; Josep A Tur; J Alfredo Martínez; M Angeles Zulet
Journal:  Nutrients       Date:  2019-02-02       Impact factor: 5.717

Review 4.  Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach.

Authors:  Ivica Grgurevic; Kristian Podrug; Ivana Mikolasevic; Michal Kukla; Anita Madir; Emmanuel A Tsochatzis
Journal:  Can J Gastroenterol Hepatol       Date:  2020-01-21

Review 5.  Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease.

Authors:  Xiaoyan Li; Hua Wang
Journal:  Cell Biosci       Date:  2020-12-07       Impact factor: 7.133

6.  Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet.

Authors:  Miaomiao Jin; Xiaohong Niu; Yan Liu; Dong Zhang; Danni Yuan; Huimin Shen
Journal:  Open Med (Wars)       Date:  2020-07-18

7.  Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study.

Authors:  Jinhua Zhang; Kangli Li; Lingling Pan; Fei Teng; Peizhen Zhang; Bingquan Lin; Youwen Yuan; Xueyun Wei; Wenyuan Li; Huijie Zhang
Journal:  BMC Gastroenterol       Date:  2021-03-21       Impact factor: 3.067

Review 8.  Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients - a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown.

Authors:  Simona Alexandra Iacob; Diana Gabriela Iacob
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-09       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.